Warace 1 Tablet

Warfarin exerts its effect by interfering with the synthesis of vitamin K-dependent clotting factors in the liver, thereby prolonging the prothrombin time and reducing blood coagulability. Dosage should be individualized based on the patient’s International Normalized Ratio (INR) values, which require regular monitoring to maintain therapeutic anticoagulation and minimize the risk of bleeding complications.

Patients should be advised to maintain consistent dietary vitamin K intake and inform healthcare providers of any concurrent medications, as numerous drug interactions can alter Warfarin’s efficacy and safety profile. Caution is warranted in patients with bleeding disorders, hepatic impairment, or pregnancy. Adverse effects primarily include bleeding, ranging from minor bruising to severe hemorrhage.

Warace 1 Tablet should be used under strict medical supervision with appropriate laboratory monitoring to ensure optimal therapeutic outcomes and patient safety.